Brekke I B, Flatmark A L
Scand J Gastroenterol Suppl. 1986;126:1-4. doi: 10.3109/00365528609091882.
From June 1983 to October 1985, 25 uremic diabetic patients aged 24 to 52 (mean 38) years were treated with combined pancreas and kidney transplantation. Mean duration of diabetes was 24 years, and end-stage renal disease was associated with severe extrarenal diabetic complications in all recipients. All transplants were harvested from cadaveric, heart-beating donors aged 5-55 years. The segmental pancreas transplant was duct-occluded with neoprene before it was transplanted to the left iliac fossa. Immunosuppressive treatment was given with cyclosporine and steroids in all cases while azathioprine was added in the last 5 cases. The one year survival of patient, kidney and pancreas was 96, 79 and 60 per cent respectively. Of 17 patients with functioning pancreas transplants, 13 are insulin independent and have normal or near normal glucose homeostasis. Based on the excellent patient survival and the improvement in quality of life experienced by the recipients, it is concluded that simultaneous transplantation of pancreas and kidney should be the treatment of choice for uremic diabetic patients when a living related kidney donor is unavailable.
1983年6月至1985年10月,对25例年龄在24至52岁(平均38岁)的尿毒症糖尿病患者进行了胰肾联合移植。糖尿病平均病程为24年,所有受者的终末期肾病均伴有严重的肾外糖尿病并发症。所有移植器官均取自5至55岁的脑死亡心跳供体。节段性胰腺移植在移植至左髂窝前用氯丁橡胶闭塞导管。所有病例均采用环孢素和类固醇进行免疫抑制治疗,最后5例加用硫唑嘌呤。患者、肾脏和胰腺的1年生存率分别为96%、79%和60%。在17例胰腺移植功能良好的患者中,13例不再依赖胰岛素,血糖稳态正常或接近正常。基于出色的患者生存率以及受者生活质量的改善,得出结论:当无法获得活体亲属肾供体时,胰肾联合移植应成为尿毒症糖尿病患者的首选治疗方法。